Aktie A142280 GREEN CROSS MEDICAL SCIENCE CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Green Cross Medical Science Corporation

Aktien

A142280

KR7142280007

A142280

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 17.05.2024 		% 5 Tage % 1. Jan.
4.100 KRW 0,00 % Intraday Chart für Green Cross Medical Science Corporation +0,37 % -14,05 %
2023 Green Cross Medical Science Corporation meldet die Ergebnisse für das erste Quartal bis zum 31. März 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Green Cross Medical Science Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
Green Cross Medical Science Corporation announced that it has received KRW 30 billion in funding from Daishin Securities Co. Ltd., Investment Arm and other investors
Green Cross Medical Science Corporation announced that it expects to receive KRW 30 billion in funding from Daishin Securities Co. Ltd., Investment Arm and other investors
Oxford Immunotec Global PLC Enters into A Memorandum of Understanding Green Cross Medical Science Corp. to Market the T-SPOT Discovery SARS-CoV-2 Kit, for the Measurement of the T Cell Immune Response to SARS-CoV-2 Infection, in South Korea
Hemotune AG announced that it has received CHF 5.1 million in funding from Green Cross Medical Science Corporation, ZKB Start-up Finance, Occident Group AG
Green Cross Medical Science Enters into Co-Development Agreement with GeneCast to Develop A New COVID-19 Detection Kit
GreenCross Medical Science Corp. cancelled the acquisition of additional 29.54% stake in CERAGEM Medisys, Inc.
GreenCross Medical Science Corp. agreed to acquire additional 29.54% stake in CERAGEM Medisys, Inc for KRW 4.6 billion.
GreenCross Medical Science Corp. announced that it has received KRW 10 billion in funding from KB Securities Co., Ltd., Investment Arm and other investors
GreenCross Medical Science Corp. announced that it has received KRW 10 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Industrial Bank of Korea, Investment Arm, and other investors
GreenCross Medical Science Corp. announced that it expects to receive KRW 10 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Industrial Bank of Korea, Investment Arm, and other investors
GreenCross Medical Science Corp. announced that it expects to receive funding from KB Securities Co., Ltd., Investment Arm and other investors
Tranche Update on GreenCross Medical Science Corp.'s Equity Buyback Plan announced on March 2, 2017.
GreenCross Medical Science Corp.'s Equity Buyback announced on March 2, 2017 has closed with 50,000 shares, representing 0.52% for KRW 536.95 million.
GreenCross Medical Science Corp. announces an Equity Buyback for 50,000 shares.
GreenCross Medical Science Corp. authorizes a Buyback Plan.
GreenCross Medical Science Corp. completed the acquisition of 21.06% stake in CERAGEM Medisys, Inc.
GreenCross Medical Science Corp. agreed to acquire a 21.06% stake in CERAGEM Medisys, Inc. for KRW 5 billion.
GreenCross Medical Science Corp. has completed an IPO in the amount of KRW 12.00 billion.
GreenCross Medical Science Corp. has filed an IPO in the amount of KRW 11.20 billion.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A142280 Aktie
  4. Nachrichten Green Cross Medical Science Corporation
  5. Andere Sprachen